Alexandra Takayesu, MD/MPH, is a board-certified adult psychiatrist at Kapiolani Hospital for Women and Children. She specializes in perinatal psychiatry and psycho-oncology and is involved in emergency, consult liaison outpatient settings.

Dr. Takayesu obtained her medical degree at the John A Burns School of Medicine. She completed her psychiatric residency at the University of Hawaii, obtained a master’s in public health from the University of Massachusetts, and completed the psychotherapy-assisted therapy certificate program from the California Institute of Integral Studies, with additional MDMA-assisted therapy MAPS training. She is an assistant professor of psychiatry at the University of Hawaii and a Hawaii State Maternal Mortality Committee member.  Her mission is to provide direct care to women, expand access to high-quality care, and study the intersection of perinatal psychiatry and psychedelic medicine.

She is a sub investigator at the Center for Psychiatric Neuroscience – 1 of 37 US sites among Cleveland Clinic, Emory & Johns Hopkins, selected to Investigate RE104 – a Novel Shorter Acting Psychedelic for Post Partum Depression. In a Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients with Postpartum Depression (PPD) – https://clinicaltrials.gov/study/NCT06342310

The Center for Psychiatric Neuroscience (CPN) mission and goal is to improve mental health through a deeper understanding of neuroscience and brain function.  It brings together & supports investigators who share a mission to understand neural mechanisms underlying psychiatric illness, to elucidate mechanisms of psychotropic drug action and to develop novel therapeutic modalities for mental illness.  CPN is part of the Clinical Research Center (CRC)